Loading company…
Qstem develops stem cell culture technologies and products for research and therapeutic applications.
Founded in 2024, Qstem develops stem cell culture systems for research and therapeutic applications, including regenerative medicine, drug discovery, and disease modeling. It serves research institutions, pharmaceutical companies, and healthcare providers. Based in Suwon-si, South Korea, the company raised KRW 2.2 billion in Seed funding in February 2026, led by FuturePlay with participation from Mashup Ventures, Hallym University Technology Holdings, and AI Angel Club.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in